Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sanofi S.A. ADR | 11 | 0 | 0 | 0 | €45.20 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €122.65 | €130.00 | 5.993% |
| Savara Inc. | 1 | 0 | 0 | 0 | €4.62 | €8.00 | 73.160% |
| SCYNEXIS Inc. | 5 | 0 | 0 | 0 | €1.66 | €3.00 | 80.723% |
| Sensorion SA | 2 | 0 | 0 | 0 | €0.67 | - | - |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.10 | €21.00 | 89.222% |
| Sutro Biopharma Inc | 18 | 0 | 0 | 0 | €3.92 | €11.05 | 181.847% |
| Syros Pharmaceuticals Inc. | 5 | 1 | 1 | 1 | €4.78 | €12.80 | 167.814% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.20 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 12 | 1 | 1 | 1 | €14.80 | €16.73 | 13.053% |
| TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.83 | €28.06 | 77.242% |
| Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
| Twist Bioscience Corp | 7 | 0 | 4 | 0 | €39.67 | €41.41 | 4.384% |
| UCB S.A. | 2 | 0 | 0 | 0 | €122.40 | - | - |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.80 | €84.74 | 118.412% |
| Uniqure B.V. | 1 | 0 | 1 | 0 | €4.56 | - | - |
| United Therapeutics | 18 | 0 | 3 | 0 | €249.10 | €288.66 | 15.881% |
| Vanda Pharmaceuticals | 4 | 0 | 1 | 0 | €4.64 | €5.00 | 7.759% |
| Verastem Inc. | 9 | 0 | 0 | 0 | €11.10 | €27.03 | 143.523% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.80 | - | - |
| Vertex Pharmaceuticals Inc. | 44 | 2 | 8 | 0 | €390.00 | €404.41 | 3.694% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.52 | - | - |
| Viking Therapeutics Inc | 6 | 0 | 3 | 0 | €74.24 | €100.00 | 34.698% |
| Viracta Therapeutics Inc. | 1 | 0 | 1 | 0 | €0.75 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €352.00 | - | - |